Verification note
AIFA approvals, SSN reimbursement criteria, and regional access rules change frequently and vary by region. Verify current status at aifa.gov.it before making treatment decisions.
If you’re in Italy and exploring GLP-1 medications, you’re in a market where access has improved significantly in the past two years. Ozempic is well-established, Wegovy is approved, Mounjaro is here. The honest picture on what’s covered, what you’ll pay privately, and how to get started looks like this.
What’s Approved and Available in Italy
AIFA (Agenzia Italiana del Farmaco) is Italy’s equivalent of the FDA. All major GLP-1 medications are approved through EMA/AIFA and available in Italian pharmacies.
| Medication | Active ingredient | AIFA approval | SSN coverage | Private cost/month |
|---|---|---|---|---|
| Ozempic | Semaglutide | Type 2 diabetes | T2D patients (criteria apply) | ~€200 to €350 |
| Wegovy | Semaglutide 2.4mg | Chronic weight management | Limited (serious comorbidities required) | ~€200 to €400 |
| Mounjaro | Tirzepatide | Type 2 diabetes | T2D with specific indications | ~€250 to €400 |
| Saxenda | Liraglutide | Chronic weight management | Limited | ~€150 to €250 |
Coverage through the Italian SSN is real but conditional. The details matter.
On Ozempic? Regimen’s Ozempic app logs the shot in one tap, reminds you before the next one, and ties your side effects and weight to each dose step.
SSN Coverage: What Actually Qualifies
For type 2 diabetes
Ozempic is covered by the SSN for T2DM patients meeting prescribing criteria. This is a well-established pathway. If you’re managing type 2 diabetes, your endocrinologist or diabetologist can prescribe Ozempic on a reimbursed basis.
Mounjaro has EMA approval for T2DM and is available in Italy, with SSN reimbursement for T2DM patients meeting specific clinical indications.
For weight management only
This is where Italy’s regional variation matters. Italy’s healthcare is regionalized: Lombardia may have different reimbursement criteria than Sicilia or Campania.
SSN coverage for weight management requires documented obesity (typically BMI 35+ or BMI 30+ with comorbidities; verify current prescribing criteria at aifa.gov.it) and specialist evaluation from a dietologist or endocrinologist. Even then, coverage isn’t guaranteed in all regions. The standard approach for weight management without qualifying comorbidities is private prescription.
Pro Tip
If you’re on the border of qualifying for SSN coverage for weight management, getting a formal obesity evaluation at a specialized center in your region (centri per il trattamento dell’obesità) can open the door to coverage. The criteria are stricter in some regions than others, but the evaluation itself is the first step worth taking before assuming private is your only option.
Private Access: The Realistic Path for Most
For weight management without qualifying T2DM or documented obesity with comorbidities, private prescription is the practical route.
Any licensed Italian physician can prescribe GLP-1 medications privately. Endocrinologists and general physicians in major Italian cities (Milan, Rome, Bologna, Florence, Naples) regularly prescribe Wegovy and Ozempic privately for weight management.
Out-of-pocket costs for Wegovy privately: approximately €200 to €400 per month depending on dose and pharmacy. Ozempic at lower doses used off-label for weight management runs slightly less. The Italian GLP-1 private market is growing and the prescriber network is expanding.
Community Insight
The most common feedback from Italian GLP-1 users: getting a prescription privately is not difficult in major cities, but pharmacies in smaller towns may need to order stock. Milan and Rome pharmacies reliably have it in hand. Outside major urban centers, call ahead.
Italy’s GLP-1 Market Context
The Italian GLP-1 market has grown significantly since 2023. Southern Italy has some of the highest obesity rates in Europe. The demand is real and the prescriber awareness is following it.
One Italy-specific note: the Italian aesthetic medicine and anti-aging scene is sophisticated, particularly in northern Italy. Private clinics in Milan and Bologna that already handle TRT and anti-aging protocols have been integrating GLP-1 prescribing naturally. If you’re already working with a men’s health or anti-aging clinic in Italy, ask about GLP-1 directly. Many now offer it.
Warning
Avoid sourcing GLP-1 medications from unregulated online suppliers. Italian customs (Agenzia delle Dogane) has stricter enforcement on imported unregistered medicines than some other European countries. Stick to pharmacy-dispensed, AIFA-approved products with a valid Italian prescription.
Tracking Your GLP-1 Protocol
Weekly GLP-1 injections come with a titration schedule that takes 4 to 5 months to complete. Tracking each dose, your weight trend, and any side effects at each tier helps you build a clear picture of how you’re responding.
Use the GLP-1 Dose Calculator to map out your titration schedule and calculate per-dose volumes.
If you want to compare tracking apps before settling on one, start with the best GLP-1 tracker apps.
If you’re also on TRT, see the Italy TRT Guide for how the two protocols interact in the Italian system.
This article is for informational purposes only and does not constitute medical advice. Discuss all treatment decisions with your healthcare provider.
Ready to track your GLP-1?
- Smart reminders so you never miss a dose
- Track weight, photos, and progress over time
- Medication level curves for every compound
Frequently Asked Questions
Is Ozempic available in Italy in 2026?
Yes. Ozempic is AIFA-approved for type 2 diabetes and available in Italian pharmacies with a valid prescription. SSN coverage applies for T2DM patients meeting prescribing criteria. Private prescription is available for weight management.
Is Wegovy available in Italy?
Yes. Wegovy is EMA-approved and available in Italy. SSN coverage for weight management is limited and regionally variable. Most patients accessing Wegovy for weight management pay privately, at approximately €200 to €400 per month.
How much does Ozempic cost privately in Italy?
Approximately €200 to €350 per month depending on dose and pharmacy. Wegovy runs €200 to €400 per month privately. Both are dispensed at standard Italian pharmacies with a valid prescription.
Can my GP prescribe GLP-1 medications in Italy?
Yes. Any licensed Italian physician can prescribe GLP-1 medications. For SSN reimbursement, specialist involvement (endocrinologist, diabetologist) is typically required. For private prescription, a GP can prescribe directly.
Does SSN coverage for GLP-1 medications vary by region in Italy?
Yes. Italy’s healthcare system is regionalized, and reimbursement criteria for GLP-1 weight management can differ between regions. Consult with a specialist in your specific region to confirm what applies to you.
